Capricor Therapeutics Shares Rise 7% After Collaboration for Covid-19 Vaccine

By Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the...

Related Keywords

Capricor Stealth ,Chris Wack ,National Institute Of Allergy ,Division Of Microbiology ,National Institutes Of Health ,Human Services Department ,Us Health ,Project Nextgen ,National Institute ,Infectious Diseases ,National Institutes ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Vaccines ,Healthcare Life Sciences ,Biopharmaceuticals ,Biological Therapy ,Specialized Drugs Medications ,Healthcare Provision ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Political General News ,Respiratory Tract Diseases ,Health ,Immunizations ,Medical Conditions ,Novel Coronaviruses ,Medical Treatments Procedures ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Medical Treatments ,Procedures ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,